Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evoke Pharma Q2 EPS $(0.93) Misses $(0.06) Estimate, Sales $2.55M Miss $2.98M Estimate

Author: Benzinga Newsdesk | August 13, 2024 08:23am

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.06) by 1450 percent. This is a 66.07 percent decrease over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $2.55 million which missed the analyst consensus estimate of $2.98 million by 14.38 percent. This is a 125.58 percent increase over sales of $1.13 million the same period last year.

Posted In: EVOK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist